These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion. Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813 [TBL] [Abstract][Full Text] [Related]
24. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion. Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970 [TBL] [Abstract][Full Text] [Related]
25. FAT1 Gene Alteration in Facioscapulohumeral Muscular Dystrophy Type 1. Park HJ; Lee W; Kim SH; Lee JH; Shin HY; Kim SM; Park KD; Lee JH; Choi YC Yonsei Med J; 2018 Mar; 59(2):337-340. PubMed ID: 29436205 [TBL] [Abstract][Full Text] [Related]
26. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach. Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058 [TBL] [Abstract][Full Text] [Related]
27. Clinical variability of facioscapulohumeral muscular dystrophy in Russia. Kazakov VM; Rudenko DI Muscle Nerve Suppl; 1995; (2):S85-95. PubMed ID: 23573592 [TBL] [Abstract][Full Text] [Related]
28. Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011. Attarian S; Salort-Campana E; Nguyen K; Behin A; Andoni Urtizberea J Rev Neurol (Paris); 2012 Dec; 168(12):910-8. PubMed ID: 22551571 [TBL] [Abstract][Full Text] [Related]
29. Low D4Z4 copy number and gender difference in Korean patients with facioscapulohumeral muscular dystrophy type 1. Park HJ; Hong JM; Lee JH; Lee HS; Shin HY; Kim SM; Ki CS; Lee JH; Choi YC Neuromuscul Disord; 2015 Nov; 25(11):859-64. PubMed ID: 26319123 [TBL] [Abstract][Full Text] [Related]
30. Balance and walking in facioscapulohumeral muscular dystrophy: multiperspective assessment. Aprile I; Padua L; Iosa M; Gilardi A; Bordieri C; Frusciante R; Russo G; Erra C; De Santis F; Ricci E Eur J Phys Rehabil Med; 2012 Sep; 48(3):393-402. PubMed ID: 22713540 [TBL] [Abstract][Full Text] [Related]
31. Postzygotic mosaicism of a novel PTPN11 mutation in monozygotic twins discordant for metachondromatosis. Rydzanicz M; Glinkowski W; Walczak A; Koppolu A; Kostrzewa G; Gasperowicz P; Pollak A; Stawiński P; Płoski R Am J Med Genet A; 2022 May; 188(5):1482-1487. PubMed ID: 35112464 [TBL] [Abstract][Full Text] [Related]
32. [Facioscapuloperoneal muscular dystrophy: correlation between a phenotype and genotype]. Rudenko DI; Kazakov BM; Skoromets AA; Magomedova NK Patol Fiziol Eksp Ter; 2009; (2):22-7. PubMed ID: 19537084 [TBL] [Abstract][Full Text] [Related]
34. [Facioscapulohumeral muscular dystrophy (FSHD)]. Funakoshi M; Goto K; Kim BY; Arahata K Nihon Rinsho; 1997 Dec; 55(12):3181-5. PubMed ID: 9436432 [TBL] [Abstract][Full Text] [Related]
35. Cloning and mapping of a very short (10-kb) EcoRI fragment associated with facioscapulohumeral muscular dystrophy (FSHD). Lee JH; Goto K; Sahashi KO; Nonaka I; Matsuda C; Arahata K Muscle Nerve Suppl; 1995; (2):S27-31. PubMed ID: 23573583 [TBL] [Abstract][Full Text] [Related]